Skip to main content
. 2023 Apr 7;25(6):725–730. doi: 10.4103/aja20234

Table 1.

Comparison of patient characteristics, hormones, testicular volume, shear wave elastography and rete testis thickness and patient distribution among the testicular volume subgroups

Variable OA (n=62) NOA (n=83) Control (n=47) P
Age (year), mean±s.d. 32±5 30±4 31±8 0.072
Serum hormone, median (IQR)
 FSH (IU l−1) 4.4 (3.5–5.6)a,c 26.5 (19.8–32.1)a,b 3.9 (3.6–6.2)b,c <0.001
 LH (IU l−1) 3.8 (3.0–5.2)a,c 9.5 (6.2–15.5)a,b 3.5 (3.1–6.2)b,c <0.001
 Testosterone (µg l−1) 3.6 (2.7–5.0) 4.0 (2.8–5.6) 3.7 (3.0–4.9) 0.498
TV (cm3), mean±s.d. 14.5±3.5a 7.2±3.6a,b 13.7±2.9b <0.001
SWE value (kPa), median (IQR) 2.6 (2.3–2.9)a 2.9 (2.4–3.5)a,b 2.5 (2.3–2.9)b <0.001
RTT (mm), median (IQR) 2.1 (1.8–2.6)a 1.6 (1.2–2.0)a,b 2.0 (1.6–2.4)b <0.001
TV subgroups (cm3), n (%)
 ≤7.0 0 (0) 81 (48.8) - <0.001
 7.1–9.0 4 (3.2) 40 (24.1) - <0.001
 9.1–11.0 19 (15.3) 24 (14.5) - 0.838
 11.1–13.0 20 (16.1) 12 (7.2) - 0.017
 ≥13.1 81 (65.3) 9 (5.4) - <0.001

aP<0.001, significant difference between OA and NOA groups; bP<0.001, significant difference between NOA and control groups; cP>0.05, similar between OA and control groups. TV: testicular volume; SWE: shear wave elastography; RTT: rete testis thickness; OA: obstructive azoospermia; NOA: nonobstructive azoospermia; s.d.: standard deviation; IQR: interquartile range; FSH: follicle-stimulating hormone; LH: luteinizing hormone; - : not applicable